Quantinno Capital Management LP Purchases 30,797 Shares of HealthEquity, Inc. $HQY

Quantinno Capital Management LP grew its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 230.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,162 shares of the company's stock after purchasing an additional 30,797 shares during the period. Quantinno Capital Management LP owned about 0.05% of HealthEquity worth $3,691,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Oxbow Advisors LLC bought a new stake in shares of HealthEquity in the first quarter worth $3,147,000. Westfield Capital Management Co. LP lifted its holdings in HealthEquity by 13.7% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company's stock valued at $178,864,000 after acquiring an additional 235,794 shares during the period. Norges Bank bought a new position in HealthEquity in the fourth quarter valued at about $66,927,000. Sumitomo Mitsui DS Asset Management Company Ltd purchased a new position in HealthEquity in the fourth quarter worth about $4,381,000. Finally, Future Fund LLC boosted its position in HealthEquity by 40.9% in the fourth quarter. Future Fund LLC now owns 44,317 shares of the company's stock worth $4,060,000 after purchasing an additional 12,854 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

NASDAQ:HQY opened at $104.63 on Friday. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The business's 50-day simple moving average is $93.37 and its two-hundred day simple moving average is $85.79. The stock has a market cap of $8.75 billion, a PE ratio of 39.19, a P/E/G ratio of 1.74 and a beta of 0.21. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $106.42.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. The business's revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HQY has been the subject of several research reports. Citigroup reaffirmed a "market outperform" rating on shares of HealthEquity in a research report on Monday, June 1st. Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research report on Monday, June 1st. BTIG Research increased their price target on shares of HealthEquity from $110.00 to $115.00 and gave the stock a "buy" rating in a research report on Friday, July 24th. Royal Bank Of Canada lifted their price target on shares of HealthEquity from $100.00 to $108.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 3rd. Finally, Weiss Ratings raised shares of HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a research report on Friday, June 5th. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of "Moderate Buy" and a consensus target price of $110.93.

Insider Buying and Selling

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the transaction, the director owned 19,733 shares of the company's stock, valued at $1,775,970. This represents a 11.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the sale, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is owned by insiders.

About HealthEquity

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source